Unknown

Dataset Information

Biodegradable biliopancreatic stents could help conserve health care resources during the COVID-19 pandemic: An observational multicenter study.


ABSTRACT:

Background

Considering limited resources for follow-up due to COVID-19, we used biodegradable stents (BPBS) for a range of biliopancreatic diseases.

Aims

This observational multicenter study aimed to evaluate technical safety and give first insights into clinical utility.

Methods

Technical success, clinical success, and necessity of follow-up visits for BPBS placed at three Austrian tertiary care hospitals between April 2020 and January 2021 were retrospectively analyzed.

Results

63 stents were deployed in 60 patients. Main indications were prophylaxis of post-ERCP pancreatitis (PEP; n = 30/63; 48%) and bridging of prolonged waiting times to cholecystectomy (n = 21/63; 33%). Median time to surgery was 47 days (range: 136 days). The technical success rate was 94

SUBMITTER: Maieron A 

PROVIDER: S-EPMC9842131 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature